HuagongsheHuagongshe Chemistry Print Report · For research reference only
(S)-morpholine-3-carboxylic acid → (R)-2-chloro-5,6,6a,7,9,10-hexahydro-[1,4]oxazino[3,4-h]pteridine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (S)-morpholine-3-carboxylic acid | HCID 1501894 | — |
| Reactant | HCID 86670087 | HCID 86670087 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | (R)-2-chloro-5,6,6a,7,9,10-hexahydro-[1,4]oxazino[3,4-h]pteridine | HCID 86670088 | — |
Reaction Steps
An enantiomeric mixture of 2-chloro-5,6,6a,7,9,10-hexahydro-[1,4]oxazino[3,4-h]pteridine (PREPARATION x2, 8 g) was dissolved in MeOH (400 mL) and was separated by supercritical fluid chromatography (SFC) (Chiralcel® AS-H (5 μm, 20×150 mm), 20% MeOH in liquid CO2 at 55 mL/min, 3 mL/injection). The peak eluting at ˜5 minutes was collected. The stereo-configuration was assigned based on a comparison of retention times of an enantiomerically-enriched sample synthesized in a manner similar to PREPARATION x1 and PREPARATION x2 using optically pure (S)-morpholine-3-carboxylic acid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09045496B2 |
| Source dataset | uspto-grants-2015_06 |
| ORD ID | ord-b885ef779c5a4fc98e7cd39bd53eb96e |
| Source note | uspto-grants-2015_06 |